Impact of depression and its treatment on the bones of growing children

Current Psychiatry Reports

Volumn 9, Issue 2, 2007, Pages 94-98

  Weller, Elizabeth B ^b   Weller, Ronald A ^b   Kloos, Angelica L ^a   Hitchcock, Stacie ^b   Kim, Woo J ^b   Zemel, Babette ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CALCIUM; CYTOKINE; DEOXYPYRIDINOLINE; GROWTH HORMONE; HYDROCORTISONE; IMIPRAMINE; INTERLEUKIN 6; LITHIUM; OSTEOCALCIN; PHOSPHATE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

BONE DENSITY; BONE DISEASE; BONE GROWTH; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE MINERALIZATION; BONE TURNOVER; CHILD BEHAVIOR; CHILD DEVELOPMENT; CIGARETTE SMOKING; CLINICAL TRIAL; CYTOKINE RELEASE; DECREASED APPETITE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXERCISE; FOOD INTAKE; FRACTURE; GROWTH HORMONE DEFICIENCY; HIP FRACTURE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INCIDENCE; MAJOR DEPRESSION; MENTAL STRESS; NUTRITIONAL DEFICIENCY; OSTEOLYSIS; OSTEOPOROSIS; PHYSICAL ACTIVITY; PHYSICAL STRESS; REVIEW; SIDE EFFECT; SUN EXPOSURE; WEIGHT BEARING;

EID: 34147202060     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-007-0077-8     Document Type: Review

References (51)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy: Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285:785-795.
2. Chan GM, Hoffman K, McMurry M: Effects of dairy products on bone and body composition in pubertal girls. J Pediatr 1995, 126:551-556.
3. Bailey DA, McKay HA, Mirwald RL, et al.: A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study. J Bone Miner Res 1999, 14:1672-1679.
4. Michelson D, Stratakis C, Hill L, et al.: Bone mineral density in women with depression. N Engl J Med 1996, 335:1176-1181.
5. Schweiger U, Deuschle M, Korner A, et al.: Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 1994, 151:1691-1693.
6. Schweiger U, Weber B, Deuschle M, Heuser I: Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-up. Am J Psychiatry 2000, 157:118-120.
7. Mussolino M: Depression and hip fracture risk: the NHANES I Epidemiologic follow-up study. Public Health Rep 2005, 120:71-75.
8. Furlan PM, Ten Have T, Cary M, et al.: The role of stress-induced cortisol in the relationship between depression and decreased bone mineral density. Biol Psychiatry 2005, 57:911-917.
9. Raison CL, Miller AH: When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003, 160:1554-1565.
10. Penninx BW, Kritchevsky SB, Yaffe K, et al.: Inflammatory markers and depressed mood in older persons: results from the Health, Aging, and Body Composition study. Biol Psychiatry 2003, 54:566-572.
11. Sugimoto T: Calcium intake and bone mass [in Japanese]. Clin Calcium 2001, 11:193-197.
12. Horrobin DF, Bennett CN: Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids 1999, 60:217-234.
13. Birmaher BD, Ryan ND, Williamson DE, et al.: Childhood and adolescent depression: a review of the past 10 years: Part I. J Am Acad Child Adolesc Psychiatry 1996, 35:1427-1439.
14. Birmaher B, Arbelaez C, Brent D: Course and outcome of child and adolescent major depressive disorder. Child Adolesc Psychiatr Clin N Am 2002, 11:619-637.
15. Johnston CC, Jr, Longcope C: Premenopausal bone loss - a risk factor for osteoporosis. N Engl J Med 1990, 323:1271-1273.
16. Matkovic V, Jelic T, Wardlaw GM, et al.: Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 1994, 93:799-808.
17. Halbreich U, Asnis GM, Shindledecker R, et al.: Cortisol secretion in endogenous depression. I: Basal plasma levels. Arch Gen Psychiatry 1985, 42:904-908.
18. Canalis E: Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996, 81:3441-3447.
19. Manolagas SC, Weisterin RS: New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999, 14:1061-1066.
20. Isaksson O: GH, IGF-I, and growth. J Pediatr Endocrinol 2004, 17(Suppl 4):1321-1326.
21. Gold P, Goodwin F, Chrousos G: Clinical and biochemical manifestations of depression in an older population. J Am Geriatr Soc 2001, 49:732-736.
22. Kudo O, Fujikawa Y, Itonaga I, et al.: Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. J Pathol 2002, 198:220-227.
23. Kudo O, Sabokbar A, Pocock A, et al.: Interleukin-6 and interleukin-11 support human osteoclast formation by RANKL-independent mechanism. Bone 2003, 32:1-7.
24. Steptoe A, Kunz-Ebrecht S, Owen N: Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 2003, 33:667-674.
25. Kagaya A, Kugaya A, Takebayashi M, et al.: Plasma concentrations of interleukin-1 beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 2001, 43:59-62.
26. Herran A, Amado J, Garcia-Unzueta M, et al.: Increased bone remodeling in first-episode major depressive disorder. Psychosom Med 2000, 62:779-782.
27. Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004, 80(6 Suppl):1678S-1688S.
28. Sun D, Krishnan A, Zaman K, et al.: Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003, 18:1206-1216.
29. Simonsick EM: Personal health habits and mental health in a national probability sample. Am J Prev Med 1991, 7:425-437.
30. Gustavsson A, Thorsen K, Nordstrom P: A 3-year longitudinal study of the effect of physical activity on the accrual of bone mineral density in healthy adolescent males. Calcif Tissue Int 2003, 73:108-114.
31. Glassman AH, Helzer JE, Covey LS, et al.: Smoking, smoking cessation, and major depression. JAMA 1990, 264:1546-1549.
32. Schoenborn CA, Horm J: Negative moods as correlates of smoking and heavier drinking: implications for health promotion. Adv Data 1993, 236:1-16.
33. Kleerekoper M, Schiebinger RJ: Skeletal recovery after treatment of Cushing's: still room for improvement. J Clin Endocrinol Metab 1995, 80:2856-2858.
34. Liu B, Anderson G, Mittmann N, et al.: Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998, 351:303-307.
35. Misra M, Papakostas GI, Klibanski A: Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry 2004, 65:1607-1618.
36. Bachrach LK: Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab 2001, 12:22-28.
37. Bonjour JP, Chevalley T, Ferrari S, Rizzoli R: Peak bone mass and its regulation. In Pediatric Bone Loss and Diseases. Edited by Glorieux F, Pettifor J, Juppner H. San Diego: Academic Press; 2003:235-248.
38. Dahl RE, Birmaher B, Williamson DE, et al.: Low growth hormone response to growth hormone-releasing hormone in child depression. Biol Psychiatry 2000, 48:981-988.
39. Monson JP, Drake WM, Carroll PV, et al.: Influence of growth hormone on accretion of bone mass. Horm Res 2002, 58(Suppl 1):52-56.
40. Luby JL, Heffelfinger A, Mrakotsky C, et al.: Alterations in stress cortisol reactivity in depressed preschoolers relative to psychiatric and no-disorder comparison groups. Arch Gen Psychiatry 2003, 60:1248-1255.
41. Di Somma C, Pivonello R, Loche S, et al.: Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease. Clin Endocrinol 2002, 56:153-158.
42. Leong GM, Mercado-Asis LB, Reynolds JC, et al.: The effect of Cushing's disease on bone mineral density, body composition, growth, and puberty: a report of an identical adolescent twin pair. J Clin Endocrinol Metab 1996, 81:1905-1911.
43. Hirota K, Hirota T: Nutrition-related bone disease [in Japanese]. Nippon Rinsho 2006, 64:1707-1711.
44. Bar-Or O: Nutritional considerations for the child athlete. Can J Appl Physiol 2001, 26(Suppl):S186-S191.
45. Bonjour JP, Carrie AL, Ferrari S, et al.: Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest 1997, 99:1287-1294.
46. Lee WT, Leung SS, Leung DM, et al.: Bone mineral acquisition in low calcium intake children following the withdrawal of calcium supplement. Acta Paediatrica 1997, 86:570-576.
47. MacKelvie KJ, Khan KM, Petit MA, et al.: A school-based exercise intervention elicits substantial bone health benefits: a two-year randomized controlled trial in girls. Pediatrics 2003, 112:e447.
48. MacKelvie KJ, Petit MA, Khan KM, et al.: Bone mass and structure are enhanced following a 2-year randomized controlled trial of exercise in prepubertal boys. Bone 2004, 34:755-764.
49. Brosnahan J, Steffen LM, Lytle L, et al.: The relation between physical activity and mental health among Hispanic and non-Hispanic white adolescents. Arch Pediatr Adolesc Med 2004, 158:818-823.
50. Warden SJ, Robling AG, Sanders MS, et al.: Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 2005, 146:685-693.
51. Weintrob N, Cohen D, Klipper-Aurbach Y, et al.: Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatr Adolesc Med 2002, 156:696-701.